Form 8-K - Current report:
SEC Accession No. 0001104659-22-129912
Filing Date
2022-12-23
Accepted
2022-12-23 16:24:36
Documents
13
Period of Report
2022-12-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2233391d1_8k.htm   iXBRL 8-K 28664
2 EXHIBIT 10.1 tm2233391d1_ex10-1.htm EX-10.1 283776
  Complete submission text file 0001104659-22-129912.txt   556807

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cgtx-20221223.xsd EX-101.SCH 3024
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgtx-20221223_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgtx-20221223_pre.xml EX-101.PRE 22589
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2233391d1_8k_htm.xml XML 3613
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40886 | Film No.: 221485644
SIC: 2836 Biological Products, (No Diagnostic Substances)